Analyst, 2023, 148,4967-4981
DOI: 10.1039/D3AN00972F, Critical Review
DOI: 10.1039/D3AN00972F, Critical Review
Xinyi Lu, Xin Wang, Susu Gao, Ziwei Chen, Ru Bai, Yaling Wang
The significant development of bioparameter-directed nanoformulations as MRI contrast agents for tumour diagnosis has been explained.
The content of this RSS Feed (c) The Royal Society of Chemistry
The significant development of bioparameter-directed nanoformulations as MRI contrast agents for tumour diagnosis has been explained.
The content of this RSS Feed (c) The Royal Society of Chemistry